Wiechens, Bernhard
Meyer-Marcotty, Philipp
Buhl, Timo
Werfel, Thomas
Bauer, Andrea
Apfelbacher, Christian
Forkel, Susann
Hollstein, Moritz M.
Traidl, Stephan
Funding for this research was provided by:
Herzzentrum Göttingen
Article History
Received: 26 June 2023
Accepted: 16 February 2024
First Online: 3 April 2024
Declarations
:
: C. Apfelbacher has received consultancy fees from the Dr Wolff Group, Sanofi Genzyme, Sanofi-Aventis Germany, Bionorica, and LEO Pharma for services related to (hand) eczema. B. Wiechens, P. Meyer-Marcotty, T. Buhl, T. Werfel, A. Bauer, S. Forkel, M.M. Hollstein and S. Traidl declare that they have no competing interests.
: This study was conducted in accordance with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards and was approved by the ethics committees of Hannover Medical School (No. 10357_B0_K_2022). It was registered with the German Clinical Trials Register prior to the start of the study (DRKS00026677) and complies with the Consensus-Based Checklist for Reporting of Survey Studies (CROSS). All participants provided written consent for the anonymous evaluation of information and the exchange of data between the participating university hospitals.